Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 13, Issue 6, Pages 980
Publisher
MDPI AG
Online
2023-06-12
DOI
10.3390/jpm13060980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics and serum CA19 ‐9 combined with HE4 are valuable in diagnosing endometriosis‐associated ovarian cancer
- (2023) Ting Xu et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Interleukin-6 and Hypoxia Synergistically Promote EMT-Mediated Invasion in Epithelial Ovarian Cancer via the IL-6/STAT3/HIF-1α Feedback Loop
- (2023) Tongshuo Zhang et al. Analytical Cellular Pathology
- Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors
- (2022) Costanza Maria Cristiani et al. Frontiers in Immunology
- The role of IL-6/JAK2/STAT3 signaling pathway in cancers
- (2022) Bei Huang et al. Frontiers in Oncology
- Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients
- (2022) Syah Mirsya Warli et al. World Journal of Oncology
- Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma
- (2021) Toshiyuki Seki et al. Scientific Reports
- The Clinical Importance of IL-6, IL-8, and TNF-α in Patients with Ovarian Carcinoma and Benign Cystic Lesions
- (2021) Weronika Pawlik et al. Diagnostics
- The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
- (2021) Izabela Szulc-Kielbik et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Correlations between peripheral blood biomarkers and clinical outcomes in advanced non-small cell lung cancer patients who received immunotherapy-based treatments
- (2021) Yuequan Shi et al. Translational Lung Cancer Research
- Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
- (2021) Hina Amer et al. Journal of Personalized Medicine
- Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer
- (2020) Nirmala Chandralega Kampan et al. Scientific Reports
- C reactive protein impairs adaptive immunity in immune cells of patients with melanoma
- (2020) Tatsuya Yoshida et al. Journal for ImmunoTherapy of Cancer
- Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms
- (2020) Douglas Côbo Micheli et al. BIOMARKERS
- Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment
- (2020) Man Cheng et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Serum CA19 ‐9, CA ‐125 and CEA as tumor markers for mucinous ovarian tumors
- (2020) Arb‐aroon Lertkhachonsuk et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- CA125 and Ovarian Cancer: A Comprehensive Review
- (2020) Parsa Charkhchi et al. Cancers
- Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
- (2019) Vincent Dochez et al. Journal of Ovarian Research
- Cytokines in peritoneal fluid of ovarian neoplasms
- (2019) Cid Almeida de Lima et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia
- (2019) Kristine Pettersen et al. Journal of Cachexia Sarcopenia and Muscle
- A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
- (2018) Chanhee Han et al. GYNECOLOGIC ONCOLOGY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer
- (2017) Ugo Pastorino et al. EUROPEAN JOURNAL OF CANCER
- Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
- (2017) Yosuke Yasuda et al. International Journal of Clinical Oncology
- CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis
- (2017) Xianjun Fang et al. MOLECULAR CARCINOGENESIS
- Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
- (2017) Boyun Kim et al. Cancer Research and Treatment
- Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients
- (2017) Junjie Hang et al. Scientific Reports
- Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort
- (2017) Claudia Agnoli et al. Scientific Reports
- Inflammatory Markers of CRP, IL6, TNF , and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies
- (2016) F. Zeng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells
- (2015) Hua Xiong et al. NEOPLASIA
- A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor α Receptor 2 Levels and Risk of Ovarian Cancer
- (2013) Elizabeth M. Poole et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway
- (2013) Liming Zhu et al. CANCER LETTERS
- A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses
- (2012) C Anton et al. Clinics
- Stromal-derived IL-6 alters the balance of myeloerythroid progenitors during Toxoplasma gondii infection
- (2012) David B. Chou et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Stat3 Mediates Expression of Autotaxin in Breast Cancer
- (2011) Janeen Azare et al. PLoS One
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started